EDAR Antikörper (AA 31-245)
Kurzübersicht für EDAR Antikörper (AA 31-245) (ABIN2620237)
Target
Alle EDAR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-245
-
Spezifität
- Human ED3 / EDAR.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Recombinant fragment corresponding to a region within amino acids 31 and 245 of EDAR (SwissProt Q9UNE0). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P (1:100 - 1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid multiple freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- EDAR (Ectodysplasin A Receptor (EDAR))
-
Andere Bezeichnung
- EDAR
-
Hintergrund
-
Name/Gene ID: EDAR
Synonyms: EDAR, Ectodysplasin-A receptor, ED1R, EDA-A1 receptor, EDA1R, DL, Downless, mouse, homolog of, ED3, EDA3, ECTD10A, ECTD10B, Ectodysplasin A receptor, ED5, Downless homolog, Ectodermal dysplasia receptor, EDA-A1R, HRM1 -
Gen-ID
- 10913
-
Pathways
- Tube Formation, Ubiquitin Proteasome Pathway
Target
-